Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines.
Identifieur interne : 001318 ( Main/Exploration ); précédent : 001317; suivant : 001319Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines.
Auteurs : Venugopalan. Nair ; C Olanow ; Stuart. SealfonSource :
- Biochemical Journal [ 0264-6021 ] ; 2003.
Abstract
Whereas dopamine agonists are known to provide symptomatic benefits for Parkinson's disease, recent clinical trials suggest that they might also be neuroprotective. Laboratory studies demonstrate that dopamine agonists can provide neuroprotective effects in a number of model systems, but the role of receptor-mediated signalling in these effects is controversial. We find that dopamine agonists have robust, concentration-dependent anti-apoptotic activity in PC12 cells that stably express human D(2L) receptors from cell death due to H(2)O(2) or trophic withdrawal and that the protective effects are abolished in the presence of D(2)-receptor antagonists. D(2) agonists are also neuroprotective in the nigral dopamine cell line SN4741, which express endogenous D(2) receptors, whereas no anti-apoptotic activity is observed in native PC12 cells, which do not express detectable D(2) receptors. Notably, the agonists studied differ in their relative efficacy to mediate anti-apoptotic effects and in their capacity to stimulate [(35)S]guanosine 5'-[gamma-thio]triphosphate ([(35)S]GTP[S]) binding, an indicator of G-protein activation. Studies with inhibitors of phosphoinositide 3-kinase (PI 3-kinase), extracellular-signal-regulated kinase or p38 mitogen-activated protein kinase indicate that the PI 3-kinase pathway is required for D(2) receptor-mediated cell survival. These studies indicate that certain dopamine agonists can complex with D(2) receptors to preferentially transactivate neuroprotective signalling pathways and to mediate increased cell survival.
Url:
DOI: 10.1042/BJ20030017
PubMed: 12683952
PubMed Central: 1223482
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000047
- to stream Pmc, to step Curation: 000047
- to stream Pmc, to step Checkpoint: 000277
- to stream Ncbi, to step Merge: 000058
- to stream Ncbi, to step Curation: 000058
- to stream Ncbi, to step Checkpoint: 000058
- to stream Main, to step Merge: 001371
- to stream Main, to step Curation: 001318
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines.</title>
<author><name sortKey="Nair, Venugopalan D" sort="Nair, Venugopalan D" uniqKey="Nair V" first="Venugopalan" last="Nair">Venugopalan. Nair</name>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C" last="Olanow">C Olanow</name>
</author>
<author><name sortKey="Sealfon, Stuart C" sort="Sealfon, Stuart C" uniqKey="Sealfon S" first="Stuart" last="Sealfon">Stuart. Sealfon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">12683952</idno>
<idno type="pmc">1223482</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1223482</idno>
<idno type="RBID">PMC:1223482</idno>
<idno type="doi">10.1042/BJ20030017</idno>
<date when="2003">2003</date>
<idno type="wicri:Area/Pmc/Corpus">000047</idno>
<idno type="wicri:Area/Pmc/Curation">000047</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000277</idno>
<idno type="wicri:Area/Ncbi/Merge">000058</idno>
<idno type="wicri:Area/Ncbi/Curation">000058</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000058</idno>
<idno type="wicri:doubleKey">0264-6021:2003:Nair V:activation:of:phosphoinositide</idno>
<idno type="wicri:Area/Main/Merge">001371</idno>
<idno type="wicri:Area/Main/Curation">001318</idno>
<idno type="wicri:Area/Main/Exploration">001318</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines.</title>
<author><name sortKey="Nair, Venugopalan D" sort="Nair, Venugopalan D" uniqKey="Nair V" first="Venugopalan" last="Nair">Venugopalan. Nair</name>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C" last="Olanow">C Olanow</name>
</author>
<author><name sortKey="Sealfon, Stuart C" sort="Sealfon, Stuart C" uniqKey="Sealfon S" first="Stuart" last="Sealfon">Stuart. Sealfon</name>
</author>
</analytic>
<series><title level="j">Biochemical Journal</title>
<idno type="ISSN">0264-6021</idno>
<idno type="e-ISSN">1470-8728</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Whereas dopamine agonists are known to provide symptomatic benefits for Parkinson's disease, recent clinical trials suggest that they might also be neuroprotective. Laboratory studies demonstrate that dopamine agonists can provide neuroprotective effects in a number of model systems, but the role of receptor-mediated signalling in these effects is controversial. We find that dopamine agonists have robust, concentration-dependent anti-apoptotic activity in PC12 cells that stably express human D(2L) receptors from cell death due to H(2)O(2) or trophic withdrawal and that the protective effects are abolished in the presence of D(2)-receptor antagonists. D(2) agonists are also neuroprotective in the nigral dopamine cell line SN4741, which express endogenous D(2) receptors, whereas no anti-apoptotic activity is observed in native PC12 cells, which do not express detectable D(2) receptors. Notably, the agonists studied differ in their relative efficacy to mediate anti-apoptotic effects and in their capacity to stimulate [(35)S]guanosine 5'-[gamma-thio]triphosphate ([(35)S]GTP[S]) binding, an indicator of G-protein activation. Studies with inhibitors of phosphoinositide 3-kinase (PI 3-kinase), extracellular-signal-regulated kinase or p38 mitogen-activated protein kinase indicate that the PI 3-kinase pathway is required for D(2) receptor-mediated cell survival. These studies indicate that certain dopamine agonists can complex with D(2) receptors to preferentially transactivate neuroprotective signalling pathways and to mediate increased cell survival.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Nair, Venugopalan D" sort="Nair, Venugopalan D" uniqKey="Nair V" first="Venugopalan" last="Nair">Venugopalan. Nair</name>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C" last="Olanow">C Olanow</name>
<name sortKey="Sealfon, Stuart C" sort="Sealfon, Stuart C" uniqKey="Sealfon S" first="Stuart" last="Sealfon">Stuart. Sealfon</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001318 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001318 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:1223482 |texte= Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12683952" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
This area was generated with Dilib version V0.6.19. |